Studies funded by the Dharam Ablashi Pilot Grant Program
| 2019 Grants | |
| Defining structural interactions that promote HHV-6 and HLA-B*13:01-associated hypersensitivity by X-ray crystallography | David Ostrov, PhD University of Florida |
| HHV-6 in the Lymphoma Microenvironment | Eve Crane, MD Weill Cornell |
| Exploration of HHV-6B in acute GVHD by IHC and PCR | Kevin Zwezdaryk, PhD Tulane University |
| Construction and Characterization of a Murine Roseolavirus BAC |
Darby Oldenburg, PhD |
| Next Generation Sequencing approach for the detection of pathogenic microbes, particularly viral pathogens of the Herpesviridae species (HHV-6A, HHV-6B, HHV-7) in Alzheimer’s Disease and Mesial Temporal Sclerosis |
Anita Huttner, MD, PhD |
|
Novel approaches to characterise iciHHV-6 gene expression and TERRA transcription |
Nicola Royle, PhD University of Leicester |
| 2018 Grants | |
| Autophagy dysregulation, HHV-6 and Alzheimer’s disease. | Mara Cirone, MD, PhD La Sapienza University of Rome |
| Immunomodulation by murine roseolovirus |
Swapneel Patel |
| Characterization of the HHV-6A/B U15 as a vFLIP | Alex Greninger, MD University of Washington |
| The effect of HHV6 viremia on thymopoiesis after hematopoietic transplantation | Stefan Nierkens, PhD University Medical Center Utrecht |
| Characterisation of iciHHV-6 integration sites using targeted enrichment coupled with sequencing on the Oxford Nanopore Technologies platform | Ruth Jarrett, MD University of Glasgow |
| Testing the effect of immunosuppressive drugs employed in transplantations on HHV-6 infection |
Niza Frenkel, PhD |
| Role of shelterin in HHV-6 integration and its association with disease in iciHHV-6 individuals |
Darren Wight, PhD |
|
Defining how HHV-6 Induces Mitochondrial Dysfunction and Metabolic Alterations in Human T-lymphoblast Lines |
Phillip West, PhD Texas A&M Health Science Center |
| Effect of HHV6-A infection on microglial cell expression |
Roberta Rizzo, PhD |